SME Times is powered by   
Search News
Just in:   • Indian rupee trades over 1 pc higher after US trade deal  • Very disappointing, does not bring any happiness into the lives of ordinary people, says Opposition on Union Budget 2026  • Union Budget 2026-27 highlights: Customs simplified, duties slashed; tax reforms ease trade and living  • PFC, REC to be restructured as part of financial sector reforms in Budget 2026-27  • Budget 2026-27 rolls out tax incentives for cooperatives 
Last updated: 27 Feb, 2025  

js.jpg India emerging as global biotech innovation hub: Jitendra Singh

js.jpg
   Top Stories
» Indian rupee trades over 1 pc higher after US trade deal
» Union Budget: Defence soars to Rs 7.85 lakh crore, big bets on electronics, biopharma and railways
» Budget 2026-27 hikes Govt capex to Rs 12.2 lakh crore in big push to infra
» India to ensure Aatmanirbharta, Budget driven by Yuvashakti: FM Sitharaman
» Cabinet approves Union Budget 2026-27
IANS | 27 Feb, 2025

With 9,000 biotech startups, India has emerged as a global biotech innovation hub, said Dr. Jitendra Singh, Union Minister of State (Independent Charge) for Science and Technology, on Wednesday.

He said this while undertaking a review of research facilities at CSIR-Institute of Microbial Technology (CSIR-IMTECH), Chandigarh.

"The number of biotech startups in India has grown exponentially from just 50 in 2014 to nearly 9,000 today, solidifying India's position as a global hub for biotech innovation," Singh said.

He informed that India now ranks third in the Asia-Pacific region and 12th globally in bio-manufacturing, underscoring the increasing importance of research in microbial genetics, infectious diseases, fermentation technology, environmental microbiology, and bioinformatics.

At the Institute, he also inspected a microbe repository and took updates on ongoing projects.

"Microbial technology is a crucial pillar of biotechnology," the MoS said, while emphasising its growing significance in shaping the next generation industrial revolution.

Crediting Prime Minister Narendra Modi for the groundbreaking New BioE3 Policy, which places a renewed focus on biomanufacturing and bio foundries, Singh underscored India's rapid progress in the biotech sector.

“India’s bioeconomy has witnessed an extraordinary surge from $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030,” he added.

Further, the Minister connected virtually with CSIR-Institute of Himalayan Bioresource Technology (CSIR-IHBT), Palampur, to inaugurate several new facilities and participate in critical scientific discussions.

He joined the EMBO Workshop on High Elevation Plant Adaptation in a Changing Climate (HEPACC) and the Industry, Farmer & Academia (IFA) Meet, inaugurated a New Tulip Garden at Palampur in Himachal Pradesh, and launched products developed by agri-startups that have been supported by the institute, fostering innovation in the agricultural sector.

"By integrating scientific research, industry collaboration, and government policies, the rich biodiversity of Himalayan states can be harnessed for economic prosperity," Singh said. He added that it will also benefit farmers and advance India’s scientific ecosystem.

 
Print the Page
Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
₹91.2
₹89.5
UK Pound
₹123.35
₹119.35
Euro
₹107
₹103.35
Japanese Yen ₹57.9 ₹56.1
As on 22 Jan, 2026
  Daily Poll
What is your primary "Make or Break" expectation from the Finance Minister this year?
 The Tax Relief
 The Working Capital Fix
 The Compliance Holiday
 The Payment Shield
 The Tech Subsidy
 All
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter